These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9114792)

  • 21. Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery.
    Jaeck D; Oussoultzoglou E; Bachellier P; Lemarque P; Weber JC; Nakano H; Wolf P
    World J Surg; 2001 Jun; 25(6):689-92. PubMed ID: 11376398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
    Chambers AJ; Pasieka JL; Dixon E; Rorstad O
    Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
    Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
    Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Indications and operative procedures for neuroendocrine liver metastases].
    Musholt TJ; Lang H
    Chirurg; 2009 Feb; 80(2):113-21. PubMed ID: 19212693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
    Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
    Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
    Moris D; Tsilimigras DI; Ntanasis-Stathopoulos I; Beal EW; Felekouras E; Vernadakis S; Fung JJ; Pawlik TM
    Surgery; 2017 Sep; 162(3):525-536. PubMed ID: 28624178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
    Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
    Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Labgaa I; Slankamenac K; Schadde E; Jibara G; Alshebeeb K; Mentha G; Clavien PA; Schwartz M
    Am J Surg; 2018 Jan; 215(1):125-130. PubMed ID: 29061283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
    Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
    Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature.
    Blonski WC; Reddy KR; Shaked A; Siegelman E; Metz DC
    World J Gastroenterol; 2005 Dec; 11(48):7676-83. PubMed ID: 16437698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.
    Le Treut YP; Delpero JR; Dousset B; Cherqui D; Segol P; Mantion G; Hannoun L; Benhamou G; Launois B; Boillot O; Domergue J; Bismuth H
    Ann Surg; 1997 Apr; 225(4):355-64. PubMed ID: 9114793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?
    Chen H; Hardacre JM; Uzar A; Cameron JL; Choti MA
    J Am Coll Surg; 1998 Jul; 187(1):88-92; discussion 92-3. PubMed ID: 9660030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver transplantation in the management of unresectable bilateral neuroendocrine metastases].
    Fernández JA; Robles R; Marín C; Ramírez M; Ramírez P; Sánchez-Bueno F; Luján J; Rodríguez JM; Parrilla P
    Cir Esp; 2005 Sep; 78(3):161-7. PubMed ID: 16420817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors.
    Olausson M; Friman S; Herlenius G; Cahlin C; Nilsson O; Jansson S; Wängberg B; Ahlman H
    Liver Transpl; 2007 Mar; 13(3):327-33. PubMed ID: 17318853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic neuroendocrine metastases: does intervention alter outcomes?
    Chamberlain RS; Canes D; Brown KT; Saltz L; Jarnagin W; Fong Y; Blumgart LH
    J Am Coll Surg; 2000 Apr; 190(4):432-45. PubMed ID: 10757381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series.
    Takahashi H; Kahramangil B; Berber E
    Surgery; 2018 Apr; 163(4):709-713. PubMed ID: 29273176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.
    Zhang XF; Beal EW; Chakedis J; Lv Y; Bagante F; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Weiss M; Pawlik TM
    J Gastrointest Surg; 2017 Nov; 21(11):1821-1830. PubMed ID: 28730354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.
    Rosenau J; Bahr MJ; von Wasielewski R; Mengel M; Schmidt HH; Nashan B; Lang H; Klempnauer J; Manns MP; Boeker KH
    Transplantation; 2002 Feb; 73(3):386-94. PubMed ID: 11884935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.
    Berber E; Flesher N; Siperstein AE
    World J Surg; 2002 Aug; 26(8):985-90. PubMed ID: 12016479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Liver transplantation in metastatic neuroendocrine tumors. Symptom-free intervals and cure possible].
    Ahlman H; Olausson M; Friman S; Herlenius G; Cahlin C; Nilsson O; Jansson S; Wängberg B
    Lakartidningen; 2007 Sep 5-11; 104(36):2519-23. PubMed ID: 17939441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.